2-((5-((4-(tert-Butyl)phenoxy)methyl)-4-(p-tolyl)-4H-1,2,4-triazol-3-yl)thio)-N-mesitylacetamide

Catalog No. :
ACDUGN701
CAS No. :
539808-77-0
Molecular Formula :
C31H36N4O2S
Molecular Weight :
528.72

IUPAC Name:2-((5-((4-(tert-butyl)phenoxy)methyl)-4-(p-tolyl)-4H-1,2,4-triazol-3-yl)thio)-N-mesitylacetamide

2-((5-((4-(tert-Butyl)phenoxy)methyl)-4-(p-tolyl)-4H-1,2,4-triazol-3-yl)thio)-N-mesitylacetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-((5-((4-(tert-Butyl)phenoxy)methyl)-4-(p-tolyl)-4H-1,2,4-triazol-3-yl)thio)-N-mesitylacetamide
IUPAC Name2-((5-((4-(tert-butyl)phenoxy)methyl)-4-(p-tolyl)-4H-1,2,4-triazol-3-yl)thio)-N-mesitylacetamide
MDL No.MFCD03460703
Molecular FormulaC31H36N4O2S
Molecular Weight528.72
SMILESO=C(NC1=C(C)C=C(C)C=C1C)CSC2=NN=C(COC3=CC=C(C(C)(C)C)C=C3)N2C4=CC=C(C)C=C4
InChI KeyBMSATKMVTVPPEQ-UHFFFAOYSA-N
SynonymSALOR-INT L444162-1EA;2-([5-[(4-TERT-BUTYLPHENOXY)METHYL]-4-(4-METHYLPHENYL)-4H-1,2,4-TRIAZOL-3-YL]SULFANYL)-N-MESITYLACETAMIDE;Acetamide, 2-[[5-[[4-(1,1-dimethylethyl)phenoxy]methyl]-4-(4-methylphenyl)-4H-1,2,4-triazol-3-yl]thio]-N-(2,4,6-trimethylphenyl)-
CAS No.539808-77-0

Synthetic Route by SureRoute

1. ACDUGN701 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCSAJ401 route compound structure diagram
    ACCSAJ4013910-51-8 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDUGN701 route product structure diagram
    ACDUGN701539808-77-0
Inquiry

2. ACDUGN701 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDUGN701 route product structure diagram
    ACDUGN701539808-77-0
Inquiry

Comments (0)